RXST

Rxsight Stock Analysis

AI Rating

Fair
  • Quality1/10
  • Growth 3/10
  • Value 1/10
Rxsight sales and earnings growth
RXST Growth
Neutral
  • Revenue Y/Y -14.05%
  • EPS Y/Y -68.66%
  • FCF Y/Y -5.20%
Rxsight gross and profit margin trends
RXST Profitability
Low
  • Gross margin 77.00%
  • EPS margin -36.60%
  • ROIC 5Y -18.34%
Rxsight net debt vs free cash flow
RXST Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -2739.3

Rxsight stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Medical Devices stocks